Tablet-Based Application for Multiple Sclerosis Cognitive Assessment

Introduction to Multiple Sclerosis

A new study has highlighted the effectiveness of a tablet-based application for assessing cognitive function in patients with Multiple Sclerosis (MS). This application demonstrates equivalency in scoring and offers an improved, faster administration process compared to traditional paper-based assessments. MS is an autoimmune disorder that disrupts neuron communication due to damage to myelin, a protein that insulates neurons and is essential for efficient signal transmission within the nervous system. Common symptoms of MS include vision problems, weakness, balance issues, and cognitive and emotional difficulties.

Challenges with Self-Reported Assessments

While self-reported assessments are frequently utilized, they often rely on patients’ subjective evaluations, which can be influenced by their emotional states rather than reflecting their true neurological condition. To standardize cognitive assessments across clinics, the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) was developed in 2010. BICAMS evaluates cognitive processing speed, learning abilities, and both visual and verbal memory, all of which are linked to the severity of MS.

Limitations of Traditional BICAMS Implementation

Despite the accuracy and sensitivity of the BICAMS test, its implementation by healthcare professionals can be cumbersome. This process typically involves significant paperwork, including printouts, manual scoring, and the transfer of scores to medical records.

Study Overview and Methodology

A recent study aimed to compare a tablet-based version of BICAMS, known as ICAM, with the original paper-based format. The primary objective was to establish equivalency between the two testing methods and to identify the advantages of using technology for a more efficient and accurate assessment. The study included patients diagnosed with MS, aged 18 to 79, who could read and write in English. All participants were informed about the study protocol and consented to take part. A total of 100 individuals were enrolled and randomly assigned to either the paper or tablet-based assessments.

Results and Findings

Statistical analysis revealed a strong and significant correlation between the two assessment methods. The tablet application reduced total assessment time by approximately 10 minutes, likely due to automated score calculations. Researchers noted that the findings should be validated in a larger sample size to confirm reproducibility. Nonetheless, the current data supports the validity and advantages of the computerized approach over the traditional paper-based method for assessing MS severity.

Benefits of the ICAM Application

The ICAM application allows for quick administration, with scoring processed in under 15 minutes—10 minutes faster than the paper version. Additionally, medical records can be updated in real-time, eliminating the need for manual score transfer and storage. These efficiencies suggest that the initial investment in tablets could ultimately save staff time in the long run.

Conclusion

The promising results of this study indicate that the ICAM application could enhance cognitive assessment for MS patients, streamlining the process and improving the overall quality of care.

References

Beier, Meghan, PhD; Alschuler, Kevin, et al. (2019). iCAMS, Assessing the Reliability of a BICAMS Tablet Application, International Journal of MS Care Preprint. EurekAlert (2019, Sep 9). New app offers faster and easier assessment for multiple sclerosis. https://www.eurekalert.org/pub_releases/2019-09/jhm-nao090619.php. Image by Niek Verlaan from Pixabay.